Concepedia

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer

M. Bontenbal, Maria Andersson, J. Wildiers, Giorgio Cocconi, Jacek Jassem, Robert Paridaens, Nicole Rotmensz, Richard Sylvester, H.T. Mouridsen, J.G.M. Klijn,

British Journal of Cancer · 1998 · 56 citations · 15 references

DOIFull text

Open access

Concepts

References

15

Risk Factors for Doxorubicin-lnduced Congestive Heart Failure

Daniel D. Von Hoff · Annals of Internal Medicine · 1979 · 2.4K citations

, , +15

Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland

J.L. Hayward, Paul P. Carbone, S Kumaoka et al. · Cancer · 1977 · 627 citations · Full text

, , +15

Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer

Alan S. Coates, Val Gebski, James F. Bishop et al. · New England Journal of Medicine · 1987 · 538 citations

, , +15

A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.

K K Jain, E. S. Casper, Nancy L. Geller et al. · Journal of Clinical Oncology · 1985 · 249 citations

, , +17

Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.

Lars Bastholt, M. Dalmark, Susanne B. Gjedde et al. · Journal of Clinical Oncology · 1996 · 173 citations

, , +17